These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35531488)

  • 1. Targeted Nutritional Supplementation for Telogen Effluvium: Multicenter Study on Efficacy of a Hydrolyzed Collagen, Vitamin-, and Mineral-Based Induction and Maintenance Treatment.
    Arias EM; Floriach N; Moreno-Arias G; Camps A; Arias S; Trüeb RM
    Int J Trichology; 2022; 14(2):49-54. PubMed ID: 35531488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium.
    Sant'Anna Addor FA; Donato LC; Melo CSA
    Clin Cosmet Investig Dermatol; 2018; 11():431-436. PubMed ID: 30237729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study.
    Milani M; Colombo F;
    Skin Res Technol; 2023 Jun; 29(6):e13381. PubMed ID: 37357646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic treatment.
    Starace M; Carpanese MA; Alessandrini A; Bruni F; Piraccini BM
    Ital J Dermatol Venerol; 2023 Feb; 158(1):55-59. PubMed ID: 36645365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical odorant application of the specific olfactory receptor OR2AT4 agonist, Sandalore
    Jimenez F; López E; Bertolini M; Alam M; Chéret J; Westgate G; Rinaldi F; Marzani B; Paus R
    J Cosmet Dermatol; 2021 Mar; 20(3):784-791. PubMed ID: 32645251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study.
    Turlier V; Darde MS; Loustau J; Mengeaud V
    J Eur Acad Dermatol Venereol; 2021 Nov; 35 Suppl 2():12-20. PubMed ID: 34668237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Miliacin encapsulated by polar lipids stimulates cell proliferation in hair bulb and improves telogen effluvium in women".
    Keophiphath M; Courbière C; Manzato L; Lamour I; Gaillard E
    J Cosmet Dermatol; 2020 Feb; 19(2):485-493. PubMed ID: 31135099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
    El-Dawla RE; Abdelhaleem M; Abdelhamed A
    Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
    Daunton A; Harries M; Sinclair R; Paus R; Tosti A; Messenger A
    Am J Clin Dermatol; 2023 Jul; 24(4):513-520. PubMed ID: 37052778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telogen Effluvium: A Review of the Literature.
    Asghar F; Shamim N; Farooque U; Sheikh H; Aqeel R
    Cureus; 2020 May; 12(5):e8320. PubMed ID: 32607303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study.
    Bedair NI; Abdelaziz AS; Abdelrazik FS; El-Kassas M; AbouHadeed MH
    Arch Dermatol Res; 2024 Jun; 316(6):336. PubMed ID: 38844670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anagen effluvium.
    Kanwar AJ; Narang T
    Indian J Dermatol Venereol Leprol; 2013; 79(5):604-12. PubMed ID: 23974578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation.
    Daly T; Daly K
    J Drugs Dermatol; 2018 Nov; 17(11):1236-1240. PubMed ID: 30500148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the relationship of digital phototrichogram findings of patients with diffuse hair loss with blood TSH, ferritin and vitamin B12 levels.
    Bilik L; Kokcam I; Esen M
    North Clin Istanb; 2024; 11(1):38-44. PubMed ID: 38357319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms.
    Rossi A; Magri F; Sernicola A; Michelini S; Caro G; Muscianese M; Di Fraia M; Chello C; Fortuna MC; Grieco T
    Skin Appendage Disord; 2021 Jul; 21(5):1-5. PubMed ID: 34373830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telogen effluvium. New concepts and review.
    Headington JT
    Arch Dermatol; 1993 Mar; 129(3):356-63. PubMed ID: 8447677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telogen effluvium.
    Harrison S; Sinclair R
    Clin Exp Dermatol; 2002 Jul; 27(5):389-5. PubMed ID: 12190639
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.